Artificial Intelligence (AI) in Healthcare Market by Function, Tools, End User

Description

List of Tables

The global artificial intelligence (AI) in healthcare market is projected to reach USD 194.79 billion by 2031 from USD 36.67 billion in 2026, at a CAGR of 39.7% during the forecast period. The AI in healthcare market is growing rapidly as hospitals and health systems increasingly deploy AI solutions to improve clinical efficiency, reduce physician burnout, and enhance patient outcomes.

Scope of the Report
Years Considered for the Study	2024-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD billion)
Segments	Offering, Function, Application, Deployment, Tool, End User
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

For example, in 2025, the Cleveland Clinic rolled out Ambience Healthcare's AI documentation platform across its US outpatient network after evaluating the technology across more than 80 specialties. The solution was adopted by over 4,000 clinicians within 15 weeks of deployment, enabling documentation for more than one million patient encounters. Additionally, in January 2026, Aultman Health System deployed Nabla's ambient AI solution across hundreds of clinicians through integration with Oracle Cerner, while AtlantiCare reported a 50% reduction in documentation time after implementing Oracle Health's Clinical AI Agent. As real-world adoption continues to expand across hospitals, clinics, and health systems, AI is expected to play an increasingly critical role in shaping the future of healthcare delivery worldwide.

Artificial Intelligence (AI) in Healthcare Market - IMG1

By deployment, the cloud-based models segment is expected to register the highest growth during the forecast period.

The AI in healthcare market is categorized into three deployment models: on-premises, cloud-based, and hybrid. The cloud-based models segment holds the largest share due to their scalability, cost-effectiveness, and accessibility. Cloud-based models facilitate real-time data processing and collaboration. They enable seamless integration, secure data storage, and rapid deployment, making them particularly well-suited for healthcare providers and payers. They provide faster, more reliable care while maintaining high-quality standards. Cloud-based AI solutions are becoming increasingly popular due to their cost-effectiveness, scalability, and support for remote access. These solutions enable seamless integration and real-time analytics. The growing adoption of telehealth and advancements in healthcare IT infrastructure further drive the demand for cloud-based models.

By end user, the hospitals & clinics segment dominated the artificial intelligence (AI) in healthcare market for healthcare providers in 2025.

By end user, the artificial intelligence (AI) in healthcare market for healthcare providers is segmented into hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers. The hospitals & clinics segment accounted for the largest share of the artificial intelligence (AI) in healthcare market for healthcare providers. This is attributed to the increasing demand for personalized medicines, precise diagnostics & surgical planning, growth in minimally invasive procedures, and the requirement for interoperability with existing systems. AI-based healthcare solutions enhance diagnostic accuracy, streamline operations, and personalize care in hospitals and clinics. They automate administrative tasks, predict patient outcomes, and enable faster decision-making with real-time data analysis. AI also supports remote monitoring, optimizes resources, and reduces costs by minimizing unnecessary treatments.

The Asia Pacific is expected to register the highest growth during the forecast period.

The artificial intelligence (AI) in healthcare market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest growing in the AI in healthcare market, driven by rapid healthcare digitalization, increasing investments in artificial intelligence, expanding adoption of electronic health records (EHRs), and strong government support for digital health initiatives. Countries such as China, India, Singapore, Japan, and South Korea are actively integrating AI into diagnostics, medical imaging, clinical decision support, and hospital workflow management. For instance, in February 2026, India launched its Strategy for AI in Healthcare (SAHI), establishing a national framework for the responsible and large-scale adoption of AI across the healthcare ecosystem. Healthcare providers across the region are also expanding AI adoption. In Singapore, the Ministry of Health is scaling generative AI for clinical documentation and AI-powered imaging solutions across the public healthcare system, while hospitals such as Ng Teng Fong General Hospital are using AI-enabled tools to improve patient management and care delivery.

The breakdown of primary participants is as mentioned below:

By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
By Designation: Directors (30%), Managers (34%), and Others (36%)
By Region: North America (40%), Europe (28%), Asia Pacific (20%), Latin America (7%), and the Middle East & Africa (5%)

Key Players

The prominent players operating in the artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), Solventum Corporation (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the artificial intelligence (AI) in healthcare market.

Research Coverage

The report analyzes the artificial intelligence (AI) in healthcare market and estimates the market size and future growth potential of various market segments by offering, function, application, deployment model, tool, end user, and region. The report also analyses factors (such as drivers, restrains, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for market stakeholders. The report also examines micromarkets in terms of their growth trends, prospects, and contributions to the total artificial intelligence (AI) in healthcare market. The report forecasts revenue for the market segments across five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will help established firms, as well as new entrants/smaller firms, gauge the market pulse, which, in turn, will help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market positions.

This report provides insights on:

Analysis of key drivers (rapid proliferation of AI in healthcare sector and growing need for improved healthcare services), restraints (shortage of skilled AI professionals handling AI-powered solutions and lack of standardized frameworks for AI and ML technologies), opportunities (strategic partnerships and collaborations among healthcare companies and AI technology providers and increase in focus on developing human-aware AI systems), challenges (concerns regarding data privacy and lack of interoperability) are factors contributing the growth of the artificial intelligence (AI) in healthcare market.
Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and software launches in the artificial intelligence (AI) in healthcare market.
Market Development: Comprehensive information on the lucrative emerging markets, offering, function, application, deployment, tool, end user, and region
Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in the artificial intelligence (AI) in healthcare market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global artificial intelligence (AI) in healthcare market, such as Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), and Epic Systems Corporation (US).

Product Code: HIT 9226

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN AI IN HEALTHCARE MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 AI IN HEALTHCARE MARKET OVERVIEW
3.2 AI IN HEALTHCARE MARKET, BY APPLICATION AND REGION
3.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Increasing need for early detection and diagnosis of diseases
  - 4.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies
  - 4.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases
  - 4.2.1.4 Rapid proliferation of AI in healthcare sector
  - 4.2.1.5 Growing inclination toward precision medicine and personalized care
- 4.2.2 RESTRAINTS
  - 4.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies
  - 4.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions
  - 4.2.2.3 Lack of standardized frameworks for AI and ML technologies
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Rising demand for AI-driven clinical decision support systems
  - 4.2.3.2 Increasing focus on developing human-aware AI systems
  - 4.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers
  - 4.2.3.4 Rising adoption of AI-enabled medical imaging and diagnostics
- 4.2.4 CHALLENGES
  - 4.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data
  - 4.2.4.2 Concerns regarding data privacy
  - 4.2.4.3 Lack of interoperability between AI solutions offered by different vendors
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
- 5.5.1 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY APPLICATION (2025)
- 5.5.2 INDICATIVE PRICING FOR AI IN HEALTHCARE MARKET, BY REGION (2025)
5.6 KEY CONFERENCES AND EVENTS, 2026-2027
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 CASE STUDY ANALYSIS
- 5.9.1 ACCELERATING LUNG CANCER DIAGNOSIS THROUGH AI ACROSS NHS HOSPITALS
- 5.9.2 STRENGTHENING PATIENT TRUST THROUGH DIGITAL PATIENT ENGAGEMENT SOLUTIONS
- 5.9.3 OPTIMIZING PATIENT ENGAGEMENT AND COMMUNICATION WITH TRUBRIDGE PATIENT CONNECT
5.10 IMPACT OF US TARIFF - OVERVIEW
- 5.10.1 INTRODUCTION
- 5.10.2 KEY TARIFF RATES
- 5.10.3 PRICE IMPACT ANALYSIS
- 5.10.4 IMPACT ON COUNTRIES/REGIONS
  - 5.10.4.1 US
  - 5.10.4.2 Europe
  - 5.10.4.3 Asia Pacific
- 5.10.5 IMPACT ON END USERS

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 MACHINE LEARNING AND DEEP LEARNING
- 6.1.2 NATURAL LANGUAGE PROCESSING
- 6.1.3 COMPUTER VISION
6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 CLOUD COMPUTING
- 6.2.2 DIGITAL TWINS
- 6.2.3 ROBOTIC PROCESS AUTOMATION
6.3 ADJACENT TECHNOLOGIES
- 6.3.1 BLOCKCHAIN
- 6.3.2 AUGMENTED REALITY AND VIRTUAL REALITY
- 6.3.3 INTERNET OF THINGS
6.4 PATENT ANALYSIS
- 6.4.1 PATENT PUBLICATION TRENDS FOR AI IN HEALTHCARE LANDSCAPE
- 6.4.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.5 FUTURE APPLICATIONS
- 6.5.1 AI-DRIVEN PRECISION MEDICINE
- 6.5.2 REAL-TIME CLINICAL DECISION SUPPORT WITH GENERATIVE AI
- 6.5.3 DISEASE PREDICTION AND EARLY INTERVENTION THROUGH PREDICTIVE ANALYTICS
- 6.5.4 AI-POWERED VIRTUAL HEALTH ASSISTANTS AND DIGITAL CARE NAVIGATION
- 6.5.5 ADVANCING AUTONOMOUS AI AGENTS FOR HEALTHCARE WORKFLOW AUTOMATION

7 REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
- 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.5 UNMET NEEDS OF VARIOUS END USERS
- 8.5.1 UNMET NEEDS
- 8.5.2 END-USER EXPECTATIONS
8.6 MARKET PROFITABILITY
8.7 IMPACT ON COUNTRIES/REGIONS
- 8.7.1 US
- 8.7.2 EUROPE
- 8.7.3 ASIA PACIFIC
8.8 IMPACT ON END USERS

9 AI IN HEALTHCARE MARKET, BY FUNCTION

9.1 INTRODUCTION
9.2 DIAGNOSIS & EARLY DETECTION
- 9.2.1 PRE-SCREENING
  - 9.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market
- 9.2.2 IVD
  - 9.2.2.1 IVD market, by technology
    - 9.2.2.1.1 Immunoassays
      - 9.2.2.1.1.1 Potential to enhance biomarker detection and laboratory automation to accelerate demand
    - 9.2.2.1.2 Clinical chemistry
      - 9.2.2.1.2.1 Ability to improve laboratory efficiency and diagnostic accuracy to spur adoption
    - 9.2.2.1.3 Molecular diagnostics
      - 9.2.2.1.3.1 Pressing need to identify viral and bacterial pathogens in infectious diseases to facilitate adoption
  - 9.2.2.2 IVD market, by application
    - 9.2.2.2.1 Image analysis & interpretation
      - 9.2.2.2.1.1 Rising focus of pathologists on analyzing tissue samples for detecting abnormalities at faster rate to fuel segmental growth
    - 9.2.2.2.2 Biomarker discovery & analysis
      - 9.2.2.2.2.1 Elevating adoption of precision medicine to create growth opportunities
    - 9.2.2.2.3 Other IVD applications
- 9.2.3 DIAGNOSTIC IMAGING
  - 9.2.3.1 Diagnostic imaging market, by application
    - 9.2.3.1.1 Disease interpretation & report analysis
      - 9.2.3.1.1.1 Proficiency in identifying disease-specific patterns and correlating findings across multiple data sources to fuel adoption
    - 9.2.3.1.2 Image captioning & annotation
      - 9.2.3.1.2.1 Increasing use of machine learning for automated image captioning to foster market growth
    - 9.2.3.1.3 Image reconstruction
      - 9.2.3.1.3.1 Greater emphasis of healthcare facilities on optimizing imaging workflows and increasing scanner throughput to augment adoption
    - 9.2.3.1.4 Other diagnostic imaging applications
  - 9.2.3.2 Diagnostic imaging market, by modality
    - 9.2.3.2.1 Magnetic resonance imaging
      - 9.2.3.2.1.1 Escalating adoption of AI across MRI workflows to enhance diagnostic confidence and improve scanner utilization to augment market growth
    - 9.2.3.2.2 Computed tomography
      - 9.2.3.2.2.1 Urgent need for efficient diagnosis to provide the right treatments to drive market
    - 9.2.3.2.3 X-ray imaging
      - 9.2.3.2.3.1 Development of innovative AI-based X-ray imaging solutions to drive market
    - 9.2.3.2.4 Ultrasound
      - 9.2.3.2.4.1 Increasing investments in developing AI-assisted ultrasound imaging auto-assessment tools to expedite market growth
    - 9.2.3.2.5 Nuclear imaging
      - 9.2.3.2.5.1 Integration of AI algorithms for quick detection and monitoring of abnormalities to facilitate market growth
    - 9.2.3.2.6 Other diagnostic imaging modalities
- 9.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION
  - 9.2.4.1 Critical need to identify high-risk patients and predict their disease progression risks to boost demand
- 9.2.5 DRUG ALLERGY ALERTING
  - 9.2.5.1 Significant focus on improving accuracy and speed of identifying allergic reactions to contribute to market growth
- 9.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS
9.3 TREATMENT PLANNING & PERSONALIZATION
- 9.3.1 PERSONALIZED TREATMENT PLANNING
  - 9.3.1.1 Precision medicine & genomic analysis
    - 9.3.1.1.1 Adoption of AI-based software for personalized treatment decisions and improved outcomes to propel market
  - 9.3.1.2 Predictive models for treatment response
    - 9.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth
  - 9.3.1.3 Treatment recommendation systems
    - 9.3.1.3.1 Competency in offering personalized, evidence-based treatment options to spike demand
- 9.3.2 PHARMACOLOGICAL THERAPY
  - 9.3.2.1 Drug response prediction
    - 9.3.2.1.1 Increasing use of AI-powered drug response prediction in oncology and chronic disease management to drive market
  - 9.3.2.2 Dosing & administration
    - 9.3.2.2.1 Capability of AI-based dosing models to adjust doses in real-time based on individual patient responses to spur demand
  - 9.3.2.3 Other pharmacological therapy functions
- 9.3.3 SURGICAL THERAPY
  - 9.3.3.1 Preoperative imaging & 3D modeling
    - 9.3.3.1.1 Widening use of AI-driven 3D modeling in orthopedic, cardiovascular, neurological surgeries to fuel market growth
  - 9.3.3.2 Intraoperative guidance & robotics
    - 9.3.3.2.1 Inclination toward minimally invasive surgeries and faster patient recovery to boost implementation
  - 9.3.3.3 Postoperative analysis & recovery
    - 9.3.3.3.1 Ability to predict recovery patterns, identify risks, and provide personalized rehabilitation plans to boost demand
- 9.3.4 RADIATION THERAPY
  - 9.3.4.1 Motion synchronization & auto contouring
    - 9.3.4.1.1 Need for precise delivery of radiation and minimum exposure to surrounding healthy tissues to reinforce segmental growth
  - 9.3.4.2 Real-time adaptive treatment delivery
    - 9.3.4.2.1 Growing focus on consistent treatment accuracy and clinical outcome optimization to strengthen demand
  - 9.3.4.3 Response assessment & quality assurance
    - 9.3.4.3.1 Ability of AI solutions to analyze medical images, treatment plans, and dosimetric data to accelerate demand
  - 9.3.4.4 Other radiation therapy functions
- 9.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY
  - 9.3.5.1 Virtual counseling & chatbots
    - 9.3.5.1.1 Potential to improve patient communication, engagement, and service efficiency to expand implementation
  - 9.3.5.2 Progress monitoring & feedback
    - 9.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market
  - 9.3.5.3 Follow-up & long-term support
    - 9.3.5.3.1 Widespread adoption of telemedicine platforms to drive market expansion
- 9.3.6 IMMUNOTHERAPY
  - 9.3.6.1 Real-time patient data monitoring
    - 9.3.6.1.1 High demand for proactive healthcare management to foster segmental growth
  - 9.3.6.2 Response & side-effect prediction
    - 9.3.6.2.1 Need for earlier detection of treatment-related risks across drugs and vaccines to support segmental growth
  - 9.3.6.3 Relapse prediction & long-term management
    - 9.3.6.3.1 Necessity for continuous patient monitoring and risk stratification to fuel demand
- 9.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS
9.4 PATIENT ENGAGEMENT & REMOTE MONITORING
- 9.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE
  - 9.4.1.1 Constant requirement for symptom management in chronic diseases to accelerate adoption of AI-powered apps
- 9.4.2 TELEHEALTH & REMOTE PATIENT MONITORING
  - 9.4.2.1 Increasing adoption of mobile health apps and wearable devices to augment segmental growth
- 9.4.3 HEALTHCARE ASSISTANCE ROBOTS
  - 9.4.3.1 Competency in improving quality of care and reducing burden on healthcare workers to promote adoption
- 9.4.4 MEDICATION REMINDERS
  - 9.4.4.1 Capability to deliver medication guidance, personalized health coaching, and care coordination to foster demand
- 9.4.5 PATIENT EDUCATION & EMPOWERMENT
  - 9.4.5.1 Need to improve treatment adherence and enhance self-management to drive market
- 9.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS
9.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE
- 9.5.1 RECURRENCE MONITORING
  - 9.5.1.1 Advancing post-treatment care through intelligent recurrence monitoring to support market growth
- 9.5.2 LONG-TERM OUTCOME PREDICTION
  - 9.5.2.1 Greater emphasis on predicting disease recurrence and survival chances to improve uptake of AI-powered medical devices
- 9.5.3 MENTAL HEALTH & SUPPORT SYSTEMS
  - 9.5.3.1 Rising focus on emotional well-being of patients with critical illness to support segmental growth
9.6 PHARMACY MANAGEMENT
- 9.6.1 EPRESCRIBING
  - 9.6.1.1 Urgent need to replace paper-based prescription to electronic platform to expedite adoption of ePrescribing solutions
- 9.6.2 MEDICATION MANAGEMENT
  - 9.6.2.1 Innovative medication management programs between healthcare professionals and pharmacists to encourage segmental growth
- 9.6.3 PHARMACY AUDIT & ANALYSIS
  - 9.6.3.1 Demand for operational excellence and improved patient care outcomes across pharmacies to create growth opportunities
- 9.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS
9.7 DATA MANAGEMENT & ANALYTICS
- 9.7.1 RISING FOCUS OF HEALTHCARE ORGANIZATIONS ON DEVELOPING PERSONALIZED TREATMENT PLANS TO SUPPORT SEGMENTAL GROWTH
9.8 AI SCRIBE
- 9.8.1 GROWING NEED TO IMPROVE CLINICIAN PRODUCTIVITY AND REDUCE DOCUMENTATION TIME TO STRENGTHEN AI SCRIBE DEPLOYMENT
9.9 CLINICAL DECISION SUPPORT SYSTEMS
- 9.9.1 INCREASING NEED FOR EVIDENCE-BASED CLINICAL DECISION-MAKING TO SPIKE ADOPTION
9.10 ADMINISTRATIVE
- 9.10.1 PATIENT REGISTRATION & SCHEDULING
  - 9.10.1.1 Rising adoption of self-service patient registration solutions to contribute to segmental growth
- 9.10.2 PATIENT ELIGIBILITY & AUTHORIZATION
  - 9.10.2.1 Growing demand for faster prior authorization workflows to facilitate market growth
- 9.10.3 REVENUE CYCLE MANAGEMENT
  - 9.10.3.1 Significant need to reduce claim denials and reimbursement delays to reinforce demand
- 9.10.4 WORKFORCE MANAGEMENT
  - 9.10.4.1 Growing need to optimize healthcare workforce utilization to create lucrative opportunities
- 9.10.5 SUPPLY CHAIN & INVENTORY MANAGEMENT
  - 9.10.5.1 Strong focus on reducing inventory costs and waste to bolster market growth
- 9.10.6 COMPLIANCE & DOCUMENTATION
  - 9.10.6.1 Increasing regulatory compliance requirements in healthcare to escalate demand for AI-based compliance & documentation
- 9.10.7 HEALTHCARE WORKFLOW MANAGEMENT
  - 9.10.7.1 Surging need for end-to-end workflow automation to foster segmental growth
- 9.10.8 ASSET MANAGEMENT
  - 9.10.8.1 Pressing need to improve equipment availability and reduce downtime to heighten demand for AI-based asset management
- 9.10.9 CUSTOMER RELATIONSHIP MANAGEMENT
  - 9.10.9.1 Growing focus on personalized patient engagement to boost segmental growth
- 9.10.10 FRAUD DETECTION & RISK MANAGEMENT
  - 9.10.10.1 Rising financial losses to drive investment in AI-based proactive risk management solutions
- 9.10.11 CYBERSECURITY
  - 9.10.11.1 Critical requirement to protect sensitive patient data to propel demand for AI-powered threat detection solutions
- 9.10.12 OTHER ADMINISTRATIVE FUNCTIONS

10 AI IN HEALTHCARE MARKET, BY OFFERING

10.1 INTRODUCTION
10.2 INTEGRATED SOLUTIONS
- 10.2.1 ESCALATING DEPLOYMENT OF ENTERPRISE-WIDE AI PLATFORMS TO CONTRIBUTE TO SEGMENTAL GROWTH
10.3 NICHE/POINT SOLUTIONS
- 10.3.1 GROWING ADOPTION OF SPECIALIZED AI APPLICATIONS FOR TARGETED CLINICAL AND ADMINISTRATIVE TASKS TO DRIVE MARKET
10.4 AI TECHNOLOGIES
- 10.4.1 HARNESSING AI FOR IMPROVED PATIENT OUTCOMES AND OPERATIONAL EFFICIENCY TO SUPPORT MARKET GROWTH
10.5 SERVICES
- 10.5.1 INCREASING FOCUS ON SEAMLESS AI DEPLOYMENT AND ONGOING SUPPORT TO FACILITATE SEGMENTAL GROWTH

11 AI IN HEALTHCARE MARKET, BY APPLICATION

11.1 INTRODUCTION
11.2 CLINICAL APPLICATIONS
- 11.2.1 NECESSITY TO ENHANCE PATIENT MONITORING AND CLINICAL DECISION-MAKING ABILITY TO SPUR DEMAND
11.3 NON-CLINICAL APPLICATIONS
- 11.3.1 REQUIREMENT TO ENHANCE OPERATIONAL EFFICIENCY, REDUCE ADMINISTRATIVE BURDEN, AND ENSURE BETTER RESOURCE ALLOCATION TO FOSTER MARKET GROWTH

12 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL

12.1 INTRODUCTION
12.2 ON-PREMISES MODEL
- 12.2.1 CRITICALITY OF DATA PRIVACY AND SECURITY TO SUPPORT DEPLOYMENT OF ON-PREMISES HEALTHCARE INFRASTRUCTURE
12.3 CLOUD-BASED MODEL
- 12.3.1 RAPID SCALABILITY AND SECURE DATA HANDLING AND INTEGRATION ATTRIBUTES TO ELEVATE DEMAND FOR CLOUD-BASED AI SOLUTIONS IN HEALTHCARE
12.4 HYBRID MODEL
- 12.4.1 FOCUS OF HEALTHCARE ORGANIZATIONS ON PROTECTING DATA WITHOUT SACRIFICING SCALABILITY TO DRIVE SEGMENTAL GROWTH

13 AI IN HEALTHCARE MARKET, BY TOOL

13.1 INTRODUCTION
13.2 MACHINE LEARNING
- 13.2.1 DEEP LEARNING
  - 13.2.1.1 Convolutional neural networks
    - 13.2.1.1.1 Ability to analyze X-rays, CT scans, and MRIs with high precision to elevate adoption
  - 13.2.1.2 Recurrent neural networks
    - 13.2.1.2.1 Competency in analyzing sequential data to predict disease progression and treatment efficacy to boost deployment
  - 13.2.1.3 Generative adversarial networks
    - 13.2.1.3.1 Capability to generate synthetic data to train AI models and address data scarcity and privacy issues to propel demand
  - 13.2.1.4 Graph neural networks
    - 13.2.1.4.1 Ability to recommend personalized treatment to stimulate adoption
  - 13.2.1.5 Other deep learning tools
- 13.2.2 SUPERVISED LEARNING
  - 13.2.2.1 Growing importance of evidence-based decision-making in predictive and diagnostic tasks to spur demand
- 13.2.3 REINFORCEMENT LEARNING
  - 13.2.3.1 Significance of precision medicine, value-based care, and intelligent clinical decision support to accelerate demand
- 13.2.4 UNSUPERVISED LEARNING
  - 13.2.4.1 Increasing need to uncover hidden insights from unstructured healthcare data to boost adoption
- 13.2.5 OTHER MACHINE LEARNING TOOLS
13.3 NATURAL LANGUAGE PROCESSING
- 13.3.1 SENTIMENT ANALYSIS
  - 13.3.1.1 Increasing adoption of AI for patient feedback analysis to contribute to market growth
- 13.3.2 PATTERN & IMAGE RECOGNITION
  - 13.3.2.1 Growing utilization of AI for early disease detection and personalized treatment planning to facilitate market expansion
- 13.3.3 AUTO CODING
  - 13.3.3.1 Elevating use of AI tools to improve claim reimbursement process to fuel market growth
- 13.3.4 CLASSIFICATION & CATEGORIZATION
  - 13.3.4.1 Business need to organize and classify healthcare data efficiently to expand AI implementation
- 13.3.5 TEXT ANALYTICS
  - 13.3.5.1 Necessity to derive insights from unstructured clinical text to enhance use of text analytics
- 13.3.6 SPEECH RECOGNITION
  - 13.3.6.1 Rising focus on reducing physician administrative burden to accelerate demand
13.4 CONTEXT-AWARE COMPUTING
- 13.4.1 DEVICE CONTEXT
  - 13.4.1.1 Integration of connected medical devices to boost demand for intelligent device-aware healthcare applications
- 13.4.2 USER CONTEXT
  - 13.4.2.1 Rising focus on individualized clinical decision support to spike demand
- 13.4.3 PHYSICAL CONTEXT
  - 13.4.3.1 Increasing adoption of AI for real-time environmental and patient context monitoring to generate demand
13.5 GENERATIVE AI
- 13.5.1 INCREASING USE OF GENERATIVE MODELS TO OFFER TAILORED INTERVENTIONS TO DRIVE MARKET
13.6 COMPUTER VISION
- 13.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS AND FRACTURES TO FUEL ADOPTION
13.7 IMAGE ANALYSIS
- 13.7.1 GROWING ADOPTION OF AI FOR EARLY DISEASE DETECTION AND DIAGNOSIS TO CONTRIBUTE TO MARKT GROWTH

14 AI IN HEALTHCARE MARKET, BY END USER

14.1 INTRODUCTION
14.2 HEALTHCARE PROVIDERS
- 14.2.1 HOSPITALS & CLINICS
  - 14.2.1.1 Increasing focus on enhancing patient outcomes through AI to expedite market expansion
- 14.2.2 AMBULATORY CARE CENTERS
  - 14.2.2.1 Rising adoption of AI to reduce care delivery costs to reinforce market growth
- 14.2.3 HOME HEALTHCARE AGENCIES & ASSISTED-LIVING FACILITIES
  - 14.2.3.1 Escalating demand for personalized and continuous patient care to accelerate market growth
- 14.2.4 DIAGNOSTIC & IMAGING CENTERS
  - 14.2.4.1 Increasing partnerships between hospitals and imaging centers to develop regulatory-cleared AI tools to support market growth
- 14.2.5 PHARMACIES
  - 14.2.5.1 Heightened need for AI-driven inventory optimization to unlock opportunities
- 14.2.6 OTHER HEALTHCARE PROVIDERS
14.3 HEALTHCARE PAYERS
- 14.3.1 PUBLIC PAYERS
  - 14.3.1.1 Increasing focus on cost optimization and fraud prevention to promote adoption of AI by public payers
- 14.3.2 PRIVATE PAYERS
  - 14.3.2.1 Leveraging AI to optimize claims management, member engagement, and value-based care programs to drive market
14.4 PATIENTS
- 14.4.1 INCREASING ADOPTION OF AI FOR PATIENT ENGAGEMENT AND SELF-CARE TO FACILITATE MARKET GROWTH
14.5 OTHER END USERS

15 AI IN HEALTHCARE MARKET, BY REGION

15.1 INTRODUCTION
15.2 NORTH AMERICA
- 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 15.2.2 US
  - 15.2.2.1 Increasing focus on personalized medicine and precision healthcare to drive market
- 15.2.3 CANADA
  - 15.2.3.1 Rising use of AI to improve disease care and patient survival and clinical workflows to drive market
15.3 EUROPE
- 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 15.3.2 GERMANY
  - 15.3.2.1 Collaborative health-related research and innovation programs and initiatives to contribute to market growth
- 15.3.3 UK
  - 15.3.3.1 Significant focus of government on early diagnosis, personalized treatments, and rapid drug development to boost AI demand
- 15.3.4 FRANCE
  - 15.3.4.1 Expanding AI-enabled digital healthcare and patient services to foster market growth
- 15.3.5 ITALY
  - 15.3.5.1 Growing deployment of AI infrastructure to ensure transparency, data protection, and patient safety to facilitate market growth
- 15.3.6 SPAIN
  - 15.3.6.1 Partnerships between scientists, medical professionals, and AI experts to develop innovative diagnostic tools to drive market
- 15.3.7 REST OF EUROPE
15.4 ASIA PACIFIC
- 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 15.4.2 CHINA
  - 15.4.2.1 Growing focus on healthcare innovation through national AI initiatives to accelerate market growth
- 15.4.3 JAPAN
  - 15.4.3.1 Strong healthcare infrastructure to drive adoption of advanced AI
- 15.4.4 INDIA
  - 15.4.4.1 Strong government support for digital health initiatives to create lucrative opportunities
- 15.4.5 AUSTRALIA
  - 15.4.5.1 Strong research ecosystem and national digital health initiatives to drive market
- 15.4.6 SOUTH KOREA
  - 15.4.6.1 National Strategy for Artificial Intelligence and Digital Healthcare Innovation Plan initiatives to support market growth
- 15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
- 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 15.5.2 BRAZIL
  - 15.5.2.1 Expanding digital health infrastructure and growing adoption of AI-enabled healthcare technologies to foster market growth
- 15.5.3 MEXICO
  - 15.5.3.1 Growing adoption of AI-driven chronic disease management platforms to stimulate market growth
- 15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST & AFRICA
- 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 15.6.2 GCC
  - 15.6.2.1 Saudi Arabia
    - 15.6.2.1.1 Accelerating AI-driven healthcare transformation under Saudi Vision 2030 to contribute to market growth
  - 15.6.2.2 UAE
    - 15.6.2.2.1 Rising focus on improving healthcare quality and delivering personalized patient care to reinforce market growth
  - 15.6.2.3 Rest of GCC
- 15.6.3 SOUTH AFRICA
  - 15.6.3.1 Expanding use of AI to enhance medical imaging, clinical decision support, and disease surveillance to drive market
- 15.6.4 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

16.1 INTRODUCTION
16.2 KEY PLAYER COMPETITIVE STRATEGY/RIGHT TO WIN, JANUARY 2023 TO JUNE 2026
16.3 REVENUE ANALYSIS, 2021-2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 16.5.1 STARS
- 16.5.2 EMERGING LEADERS
- 16.5.3 PERVASIVE PLAYERS
- 16.5.4 PARTICIPANTS
- 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 16.5.5.1 Company footprint
  - 16.5.5.2 Region footprint
  - 16.5.5.3 Application footprint
  - 16.5.5.4 Tool footprint
  - 16.5.5.5 Function footprint
  - 16.5.5.6 Offering footprint
  - 16.5.5.7 Deployment footprint
  - 16.5.5.8 End user footprint
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 16.6.1 PROGRESSIVE COMPANIES
- 16.6.2 RESPONSIVE COMPANIES
- 16.6.3 DYNAMIC COMPANIES
- 16.6.4 STARTING BLOCKS
- 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  - 16.6.5.1 Detailed list of key startups/SMEs
  - 16.6.5.2 Company footprint (startups/SMEs)
16.7 COMPANY VALUATION AND FINANCIAL METRICS
- 16.7.1 FINANCIAL METRICS
- 16.7.2 COMPANY VALUATION
16.8 BRAND/PRODUCT COMPARISON
16.9 COMPETITIVE SCENARIO
- 16.9.1 PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
- 16.9.2 DEALS
- 16.9.3 OTHER DEVELOPMENTS

17 COMPANY PROFILES

17.1 KEY PLAYERS
- 17.1.1 KONINKLIJKE PHILIPS N.V.
  - 17.1.1.1 Business overview
  - 17.1.1.2 Products & services offered
  - 17.1.1.3 Recent developments
    - 17.1.1.3.1 Product launches/enhancements/approvals
    - 17.1.1.3.2 Deals
    - 17.1.1.3.3 Expansions
    - 17.1.1.3.4 Other developments
  - 17.1.1.4 MnM view
    - 17.1.1.4.1 Right to win
    - 17.1.1.4.2 Strategic choices
    - 17.1.1.4.3 Weaknesses & competitive threats
- 17.1.2 MICROSOFT CORPORATION
  - 17.1.2.1 Business overview
  - 17.1.2.2 Products & services offered
  - 17.1.2.3 Recent developments
    - 17.1.2.3.1 Product launches/enhancements/approvals
    - 17.1.2.3.2 Deals
  - 17.1.2.4 MnM view
    - 17.1.2.4.1 Right to win
    - 17.1.2.4.2 Strategic choices
    - 17.1.2.4.3 Weaknesses & competitive threats
- 17.1.3 NVIDIA CORPORATION
  - 17.1.3.1 Business overview
  - 17.1.3.2 Products & services offered
  - 17.1.3.3 Recent developments
    - 17.1.3.3.1 Product launches/enhancements/approvals
    - 17.1.3.3.2 Deals
  - 17.1.3.4 MnM view
    - 17.1.3.4.1 Right to win
    - 17.1.3.4.2 Strategic choices
    - 17.1.3.4.3 Weaknesses & competitive threats
- 17.1.4 SIEMENS HEALTHINEERS AG
  - 17.1.4.1 Business overview
  - 17.1.4.2 Products & services offered
  - 17.1.4.3 Recent developments
    - 17.1.4.3.1 Product launches/enhancements/approvals
    - 17.1.4.3.2 Deals
  - 17.1.4.4 MnM view
    - 17.1.4.4.1 Right to win
    - 17.1.4.4.2 Strategic choices
    - 17.1.4.4.3 Weaknesses & competitive threats
- 17.1.5 GE HEALTHCARE
  - 17.1.5.1 Business overview
  - 17.1.5.2 Products & services offered
  - 17.1.5.3 Recent developments
    - 17.1.5.3.1 Product launches/enhancements/approvals
    - 17.1.5.3.2 Deals
    - 17.1.5.3.3 Other developments
  - 17.1.5.4 MnM view
    - 17.1.5.4.1 Right to win
    - 17.1.5.4.2 Strategic choices
    - 17.1.5.4.3 Weaknesses & competitive threats
- 17.1.6 EPIC SYSTEMS CORPORATION
  - 17.1.6.1 Business overview
  - 17.1.6.2 Products & services offered
  - 17.1.6.3 Recent developments
    - 17.1.6.3.1 Product launches/enhancements/approvals
    - 17.1.6.3.2 Deals
- 17.1.7 ORACLE
  - 17.1.7.1 Business overview
  - 17.1.7.2 Products & services offered
  - 17.1.7.3 Recent developments
    - 17.1.7.3.1 Product launches/enhancements/approvals
    - 17.1.7.3.2 Deals
    - 17.1.7.3.3 Expansions
- 17.1.8 VERADIGM INC.
  - 17.1.8.1 Business overview
  - 17.1.8.2 Products & services offered
  - 17.1.8.3 Recent developments
    - 17.1.8.3.1 Product launches/enhancements/approvals
    - 17.1.8.3.2 Deals
- 17.1.9 AMAZON WEB SERVICES, INC.
  - 17.1.9.1 Business overview
  - 17.1.9.2 Products & services offered
  - 17.1.9.3 Recent developments
    - 17.1.9.3.1 Product launches/enhancements/approvals
    - 17.1.9.3.2 Deals
    - 17.1.9.3.3 Expansions
- 17.1.10 MERATIVE
  - 17.1.10.1 Business overview
  - 17.1.10.2 Products & services offered
  - 17.1.10.3 Recent developments
    - 17.1.10.3.1 Product launches/enhancements/approvals
    - 17.1.10.3.2 Deals
- 17.1.11 IBM
  - 17.1.11.1 Business overview
  - 17.1.11.2 Products & services offered
  - 17.1.11.3 Recent developments
    - 17.1.11.3.1 Deals
- 17.1.12 MEDTRONIC
  - 17.1.12.1 Business overview
  - 17.1.12.2 Products & services offered
  - 17.1.12.3 Recent developments
    - 17.1.12.3.1 Product launches/enhancements/approvals
    - 17.1.12.3.2 Deals
- 17.1.13 GOOGLE
  - 17.1.13.1 Business overview
  - 17.1.13.2 Products & services offered
  - 17.1.13.3 Recent developments
    - 17.1.13.3.1 Product launches/enhancements/approvals
    - 17.1.13.3.2 Deals
    - 17.1.13.3.3 Other developments
- 17.1.14 SOPHIA GENETICS
  - 17.1.14.1 Business overview
  - 17.1.14.2 Products & services offered
  - 17.1.14.3 Recent developments
    - 17.1.14.3.1 Product launches/enhancements/approvals
    - 17.1.14.3.2 Deals
    - 17.1.14.3.3 Other developments
- 17.1.15 JOHNSON & JOHNSON SERVICES, INC.
  - 17.1.15.1 Business overview
  - 17.1.15.2 Products & services offered
  - 17.1.15.3 Recent developments
    - 17.1.15.3.1 Product launches/enhancements/approvals
    - 17.1.15.3.2 Deals
- 17.1.16 TEMPUS AI, INC.
  - 17.1.16.1 Business overview
  - 17.1.16.2 Products & services offered
  - 17.1.16.3 Recent developments
    - 17.1.16.3.1 Product launches/enhancements/approvals
    - 17.1.16.3.2 Deals
- 17.1.17 CONCERTAI
  - 17.1.17.1 Business overview
  - 17.1.17.2 Products & services offered
  - 17.1.17.3 Recent developments
    - 17.1.17.3.1 Product launches/enhancements/approvals
    - 17.1.17.3.2 Deals
- 17.1.18 SOLVENTUM CORPORATION
  - 17.1.18.1 Business overview
  - 17.1.18.2 Products & services offered
  - 17.1.18.3 Recent developments
    - 17.1.18.3.1 Deals
    - 17.1.18.3.2 Other developments
- 17.1.19 COGNIZANT
  - 17.1.19.1 Business overview
  - 17.1.19.2 Products & services offered
  - 17.1.19.3 Recent developments
    - 17.1.19.3.1 Product launches/enhancements/approvals
    - 17.1.19.3.2 Deals
- 17.1.20 VIZ.AI, INC.
  - 17.1.20.1 Business overview
  - 17.1.20.2 Products & services offered
  - 17.1.20.3 Recent developments
    - 17.1.20.3.1 Product launches/enhancements/approvals
    - 17.1.20.3.2 Deals
    - 17.1.20.3.3 Other developments
- 17.1.21 RIVERAIN TECHNOLOGIES
  - 17.1.21.1 Business overview
  - 17.1.21.2 Products & services offered
  - 17.1.21.3 Recent developments
    - 17.1.21.3.1 Product launches/enhancements/approvals
    - 17.1.21.3.2 Deals
17.2 OTHER PLAYERS
- 17.2.1 QVENTUS
- 17.2.2 QURE.AI
- 17.2.3 SUKI AI, INC.
- 17.2.4 ENLITIC
- 17.2.5 SEGMED

18 RESEARCH METHODOLOGY

18.1 RESEARCH DATA
- 18.1.1 SECONDARY DATA
  - 18.1.1.1 Key data from secondary sources
- 18.1.2 PRIMARY DATA
  - 18.1.2.1 Key data from primary sources
  - 18.1.2.2 Key industry insights
18.2 MARKET SIZE ESTIMATION
18.3 DATA TRIANGULATION
18.4 MARKET SHARE ESTIMATION
18.5 RESEARCH ASSUMPTIONS
18.6 RESEARCH LIMITATIONS
- 18.6.1 METHODOLOGY-RELATED LIMITATIONS
- 18.6.2 SCOPE-RELATED LIMITATIONS
18.7 RISK ASSESSMENT

19 APPENDIX

19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS

Product Code: HIT 9226

List of Tables

TABLE 1 INCLUSIONS AND EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS
TABLE 4 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 5 AI IN HEALTHCARE MARKET: ROLE IN ECOSYSTEM
TABLE 6 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY NON-CLINICAL APPLICATION (2025)
TABLE 7 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY CLINICAL APPLICATION (2025)
TABLE 8 CASE 1: AI-ENABLED LUNG CANCER DIAGNOSIS IN NHS HOSPITALS
TABLE 9 CASE 2: AI-DRIVEN PATIENT ENGAGEMENT IN CHILDREN'S HEALTHCARE
TABLE 10 CASE 3: DIGITAL PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12 EXPECTED CHANGE IN PRICES AND LIKELY IMPACT ON END-USE MARKET DUE TO TARIFF IMPACT
TABLE 13 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN HEALTHCARE SECTOR
TABLE 14 AI IN HEALTHCARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2022-2024
TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 NORTH AMERICA
TABLE 19 EUROPE
TABLE 20 ASIA PACIFIC
TABLE 21 MIDDLE EAST & AFRICA
TABLE 22 LATIN AMERICA
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP 3 END USERS (%)
TABLE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS
TABLE 25 UNMET NEEDS IN AI IN HEALTHCARE MARKET
TABLE 26 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET
TABLE 27 EXPECTED CHANGE IN PRICES AND ANTICIPATED IMPACT ON END USERS DUE TO TARIFF IMPACT
TABLE 28 AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 29 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 30 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 31 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2024-2031 (USD MILLION)
TABLE 32 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2024-2031 (USD MILLION)
TABLE 33 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 34 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2024-2031 (USD MILLION)
TABLE 35 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2024-2031 (USD MILLION)
TABLE 36 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 37 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 38 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 40 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 41 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 43 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING, BY REGION, 2024-2031 (USD MILLION)
TABLE 47 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 48 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2024-2031 (USD MILLION)
TABLE 50 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 54 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2024-2031 (USD MILLION)
TABLE 56 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 58 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 60 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 61 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 62 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2024-2031 (USD MILLION)
TABLE 63 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 65 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 66 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 69 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 70 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2024-2031 (USD MILLION)
TABLE 72 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 73 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 75 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 81 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2024-2031 (USD MILLION)
TABLE 85 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 86 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 87 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2024-2031 (USD MILLION)
TABLE 88 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 90 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 91 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 92 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY REGION, 2024-2031 (USD MILLION)
TABLE 93 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2024-2031 (USD MILLION)
TABLE 94 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 96 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 97 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 98 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 99 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 100 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 101 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2024-2031 (USD MILLION)
TABLE 102 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 103 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 104 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 105 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY REGION,

024-2031 (USD MILLION)

TABLE 106 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2024-2031 (USD MILLION)
TABLE 107 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 108 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 109 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 110 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 111 AI IN HEALTHCARE MARKET FOR AI SCRIBE, BY REGION, 2024-2031 (USD MILLION)
TABLE 112 AI IN HEALTHCARE MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 113 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 114 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY REGION, 2024-2031 (USD MILLION)
TABLE 115 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2024-2031 (USD MILLION)
TABLE 116 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 117 AI IN HEALTHCARE MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 118 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 119 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 120 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 121 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 122 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 123 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 124 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 125 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2024-2031 (USD MILLION)
TABLE 126 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 127 AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 128 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 129 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 130 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 131 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 132 AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 133 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 134 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 135 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 136 AI IN HEALTHCARE MARKET FOR ON-PREMISES MODEL, BY REGION, 2024-2031 (USD MILLION)
TABLE 137 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODEL, BY REGION, 2024-2031 (USD MILLION)
TABLE 138 AI IN HEALTHCARE MARKET FOR HYBRID MODEL, BY REGION, 2024-2031 (USD MILLION)
TABLE 139 AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 140 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 141 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 142 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 144 AI IN HEALTHCARE MARKET FOR CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2024-2031 (USD MILLION)
TABLE 145 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS, BY REGION, 2024-2031 (USD MILLION)
TABLE 146 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS, BY REGION, 2024-2031 (USD MILLION)
TABLE 147 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS, BY REGION, 2024-2031 (USD MILLION)
TABLE 148 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 149 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 150 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 151 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2024-2031 (USD MILLION)
TABLE 152 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 153 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 154 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY REGION, 2024-2031 (USD MILLION)
TABLE 155 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 156 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2024-2031 (USD MILLION)
TABLE 157 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2024-2031 (USD MILLION)
TABLE 158 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 159 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 160 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2024-2031 (USD MILLION)
TABLE 161 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 162 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2024-2031 (USD MILLION)
TABLE 163 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2024-2031 (USD MILLION)
TABLE 164 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2024-2031 (USD MILLION)
TABLE 165 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2024-2031 (USD MILLION)
TABLE 166 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2024-2031 (USD MILLION)
TABLE 167 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2024-2031 (USD MILLION)
TABLE 168 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 169 AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 170 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 172 AI IN HEALTHCARE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 173 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 174 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED-LIVING FACILITIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 175 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 176 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 177 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 178 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 179 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 180 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 181 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 182 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 183 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 184 AI IN HEALTHCARE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 185 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 186 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 187 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 188 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 189 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 190 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 191 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 193 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 198 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 202 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 205 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 206 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 207 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 208 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 212 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 213 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 214 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 215 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 216 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 217 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 218 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 219 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 220 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 221 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 222 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 224 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 226 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 229 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 233 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 234 US: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 235 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 236 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 238 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 239 US: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 240 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 242 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 243 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 244 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 245 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 246 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 247 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 248 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 249 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 250 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 253 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 254 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 256 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 257 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 259 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 260 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 261 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 262 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 263 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 265 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 268 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 269 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 271 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 272 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 273 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 274 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 275 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 276 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 277 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 278 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 280 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 281 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 283 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 284 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 285 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 289 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 290 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 291 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 292 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 294 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 295 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 296 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 297 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 300 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 301 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 302 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 303 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 304 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 305 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 306 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 307 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 308 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 312 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 313 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 316 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 317 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 318 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 319 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 320 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 325 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 326 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 328 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 329 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 330 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 331 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 332 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 333 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 334 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 335 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 336 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 337 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 338 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 339 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 340 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 342 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 343 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 346 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 347 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 348 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 350 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 351 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 352 UK: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 353 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 354 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 356 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 357 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 359 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 360 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 361 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 362 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 363 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 364 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 365 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 366 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 369 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 370 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 371 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 372 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 373 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 374 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 375 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 376 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 377 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 378 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 380 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 381 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 382 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 383 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 384 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 385 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 386 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 387 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 388 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 389 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 390 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 392 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 393 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 394 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 395 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 396 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 397 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 398 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 399 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 400 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 401 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 402 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 403 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 404 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 405 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 406 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 407 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 408 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 409 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 410 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 411 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 412 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 413 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 414 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 415 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 416 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 417 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 418 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 420 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 421 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 422 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 423 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 424 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 425 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 426 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 428 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 429 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 430 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 431 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 432 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 433 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 434 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 435 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 436 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 437 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 438 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 439 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 440 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 441 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 442 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 443 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 444 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 445 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 446 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 447 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 448 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 449 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 450 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 451 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 452 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 453 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 454 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 455 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 456 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 457 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 458 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 459 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 460 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 461 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 462 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 463 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 464 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 465 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 466 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 467 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 468 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 469 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 470 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 471 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 472 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 473 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 474 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 475 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 476 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 477 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 478 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 479 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 480 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 481 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 482 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 483 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 484 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 485 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 486 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 487 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 488 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 489 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 490 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 491 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 492 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 493 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 494 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 495 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 496 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 497 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 498 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 499 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 500 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 501 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 502 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 503 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 504 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 505 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 506 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 507 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 508 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 509 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 510 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 511 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 512 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 513 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 514 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 515 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 516 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 517 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 518 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 519 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 520 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 521 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 522 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 523 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 524 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 525 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 526 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 527 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 528 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 529 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 530 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 531 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 532 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 533 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 534 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 535 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 536 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 537 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 538 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 539 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 540 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 541 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 542 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 543 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 544 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 545 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 546 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 547 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 548 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 549 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 550 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 551 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 552 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 553 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 554 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 555 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 556 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 557 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 558 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 559 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 560 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 561 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 562 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 563 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 564 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 565 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 566 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 567 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 568 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 569 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 570 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 571 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 572 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 573 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 574 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 575 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 576 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 577 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 578 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 579 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 580 AUSTRALIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 581 AUSTRALIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 582 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 583 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 584 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 585 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 586 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 587 AUSTRALIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 588 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 589 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 590 AUSTRALIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 591 AUSTRALIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 592 AUSTRALIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 593 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 594 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 595 AUSTRALIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 596 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 597 AUSTRALIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 598 AUSTRALIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 599 AUSTRALIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 600 AUSTRALIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 601 AUSTRALIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 602 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 603 AUSTRALIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 604 AUSTRALIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 605 AUSTRALIA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 606 AUSTRALIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 607 AUSTRALIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 608 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 609 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 610 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 611 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 612 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 613 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 614 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 615 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 616 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 617 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 618 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 619 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 620 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 621 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 622 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 623 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 624 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 625 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 626 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 627 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 628 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 629 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 630 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 631 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 632 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 633 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 634 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 635 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 636 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 637 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 638 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 639 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 640 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 641 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 642 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 643 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 644 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 645 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 646 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 647 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 648 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 649 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 650 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 651 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 652 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 653 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 654 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 655 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 656 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 657 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 658 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 659 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 660 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 661 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 662 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 663 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 664 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 665 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 666 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 667 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 668 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 669 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 670 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 671 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 672 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 673 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 674 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 675 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 676 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 677 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 678 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 679 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 680 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 681 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 682 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 683 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 684 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 685 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 686 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 687 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 688 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 689 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 690 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 691 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 692 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 693 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 694 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 695 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 696 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 697 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 698 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 699 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 700 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 701 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 702 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 703 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 704 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 705 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 706 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 707 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 708 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 709 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 710 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 711 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 712 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 713 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 714 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 715 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 716 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 717 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 718 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 719 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 720 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 721 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 722 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 723 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 724 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 725 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 726 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 727 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 728 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 729 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 730 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 731 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 732 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 733 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 734 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 735 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 736 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 737 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 738 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 739 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 740 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 741 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 742 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 743 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 744 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 745 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 746 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 747 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 748 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 749 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 750 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 751 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 752 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 753 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 754 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 755 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 756 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 757 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 758 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 759 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 760 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 761 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 762 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 763 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 764 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 765 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 766 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 767 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 768 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 769 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 770 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 771 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 772 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 773 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 774 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 775 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 776 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 777 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 778 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 779 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 780 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 781 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 782 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 783 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 784 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 785 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 786 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 787 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 788 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 789 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 790 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 791 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 792 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 793 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 794 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 795 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 796 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 797 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 798 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 799 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 800 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 801 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 802 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 803 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 804 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 805 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 806 GCC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 807 GCC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 808 GCC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 809 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 810 GCC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 811 GCC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 812 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 813 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 814 GCC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 815 GCC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 816 GCC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 817 GCC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 818 GCC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 819 GCC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 820 GCC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 821 GCC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 822 GCC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 823 GCC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 824 GCC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 825 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 826 GCC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 827 GCC: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 828 GCC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 829 GCC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 830 GCC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 831 GCC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 832 GCC: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 833 GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 834 GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 835 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 836 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 837 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 838 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 839 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 840 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 841 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 842 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 843 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 844 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 845 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 846 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 847 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 848 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 849 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 850 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 851 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 852 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 853 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 854 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 855 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 856 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 857 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 858 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 859 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 860 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 861 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 862 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 863 UAE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 864 UAE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 865 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 866 UAE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 867 UAE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 868 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 869 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 870 UAE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 871 UAE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 872 UAE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 873 UAE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 874 UAE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 875 UAE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 876 UAE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 877 UAE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 878 UAE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 879 UAE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 880 UAE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 881 UAE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 882 UAE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 883 UAE: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 884 UAE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 885 UAE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 886 UAE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 887 UAE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 888 UAE: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 889 UAE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 890 UAE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 891 REST OF GCC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 892 REST OF GCC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 893 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 894 REST OF GCC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 895 REST OF GCC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 896 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 897 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 898 REST OF GCC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 899 REST OF GCC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 900 REST OF GCC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 901 REST OF GCC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 902 REST OF GCC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 903 REST OF GCC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 904 REST OF GCC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 905 REST OF GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 906 REST OF GCC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 907 REST OF GCC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 908 REST OF GCC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 909 REST OF GCC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 910 REST OF GCC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 911 REST OF GCC: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 912 REST OF GCC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 913 REST OF GCC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 914 REST OF GCC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 915 REST OF GCC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 916 REST OF GCC: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 917 REST OF GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 918 REST OF GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 919 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 920 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 921 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 922 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 923 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 924 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 925 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 926 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 927 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 928 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 929 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 930 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 931 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 932 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 933 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 934 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 935 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 936 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 937 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 938 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 939 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 940 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 941 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 942 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 943 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 944 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 945 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 946 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 947 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 948 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 949 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 950 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 951 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 952 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 953 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 954 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024-2031 (USD MILLION)
TABLE 955 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 956 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 957 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 958 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 959 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 960 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024-2031 (USD MILLION)
TABLE 961 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 962 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 963 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024-2031 (USD MILLION)
TABLE 964 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 965 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 966 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024-2031 (USD MILLION)
TABLE 967 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024-2031 (USD MILLION)
TABLE 968 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 969 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 970 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 971 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 972 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 973 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 974 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 975 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2023-JUNE 2026
TABLE 976 AI IN HEALTHCARE MARKET SHARE ANALYSIS, 2025
TABLE 977 AI IN HEALTHCARE MARKET: REGION FOOTPRINT
TABLE 978 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT
TABLE 979 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT
TABLE 980 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT, 2025
TABLE 981 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT
TABLE 982 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT
TABLE 983 AI IN HEALTHCARE MARKET: END USER FOOTPRINT, 2025
TABLE 984 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS, 2025
TABLE 985 AI IN HEALTHCARE MARKET: APPLICATION AND REGIONAL FOOTPRINT (STARTUPS/SMES), 2025
TABLE 986 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS, JANUARY 2023-JUNE 2026
TABLE 987 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2023-JUNE 2026
TABLE 988 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 989 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 990 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
TABLE 991 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 992 KONINKLIJKE PHILIPS N.V.: DEALS
TABLE 993 KONINKLIJKE PHILIPS N.V.: EXPANSIONS
TABLE 994 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS
TABLE 995 MICROSOFT CORPORATION: COMPANY OVERVIEW
TABLE 996 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 997 MICROSOFT CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 998 MICROSOFT CORPORATION: DEALS
TABLE 999 NVIDIA CORPORATION: COMPANY OVERVIEW
TABLE 1000 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 1001 NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1002 NVIDIA CORPORATION: DEALS
TABLE 1003 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 1004 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
TABLE 1005 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1006 SIEMENS HEALTHINEERS AG: DEALS
TABLE 1007 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 1008 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
TABLE 1009 GE HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1010 GE HEALTHCARE: DEALS
TABLE 1011 GE HEALTHCARE: OTHER DEVELOPMENTS
TABLE 1012 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 1013 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 1014 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1015 EPIC SYSTEMS CORPORATION: DEALS
TABLE 1016 ORACLE: COMPANY OVERVIEW
TABLE 1017 ORACLE: PRODUCTS & SERVICES OFFERED
TABLE 1018 ORACLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1019 ORACLE CORPORATION: DEALS
TABLE 1020 ORACLE: EXPANSIONS
TABLE 1021 VERADIGM LLC: COMPANY OVERVIEW
TABLE 1022 VERADIGM LLC: PRODUCTS & SERVICES OFFERED
TABLE 1023 VERADIGM LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1024 VERADIGM LLC: DEALS
TABLE 1025 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW
TABLE 1026 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 1027 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1028 AMAZON WEB SERVICES, INC.: DEALS
TABLE 1029 AMAZON WEB SERVICES, INC.: EXPANSIONS
TABLE 1030 MERATIVE: COMPANY OVERVIEW
TABLE 1031 MERATIVE: PRODUCTS & SERVICES OFFERED
TABLE 1032 MERATIVE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1033 MERATIVE: DEALS
TABLE 1034 IBM: COMPANY OVERVIEW
TABLE 1035 IBM: PRODUCTS & SERVICES OFFERED
TABLE 1036 IBM: DEALS
TABLE 1037 MEDTRONIC: COMPANY OVERVIEW
TABLE 1038 MEDTRONIC: PRODUCTS & SERVICES OFFERED
TABLE 1039 MEDTRONIC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1040 MEDTRONIC: DEALS
TABLE 1041 GOOGLE: COMPANY OVERVIEW
TABLE 1042 GOOGLE: PRODUCTS & SERVICES OFFERED
TABLE 1043 GOOGLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1044 GOOGLE: DEALS
TABLE 1045 GOOGLE: OTHER DEVELOPMENTS
TABLE 1046 SOPHIA GENETICS: COMPANY OVERVIEW
TABLE 1047 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED
TABLE 1048 SOPHIA GENETICS: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1049 SOPHIA GENETICS: DEALS
TABLE 1050 SOPHIA GENETICS: OTHER DEVELOPMENTS
TABLE 1051 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
TABLE 1052 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 1053 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1054 JOHNSON & JOHNSON SERVICES, INC.: DEALS
TABLE 1055 TEMPUS AI, INC.: COMPANY OVERVIEW
TABLE 1056 TEMPUS AI, INC.: PRODUCTS & SERVICES OFFERED
TABLE 1057 TEMPUS AI, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1058 TEMPUS AI, INC.: DEALS
TABLE 1059 CONCERTAI: COMPANY OVERVIEW
TABLE 1060 CONCERTAI: PRODUCTS & SERVICES OFFERED
TABLE 1061 CONCERTAI: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1062 CONCERTAI: DEALS
TABLE 1063 SOLVENTUM CORPORATION: COMPANY OVERVIEW
TABLE 1064 SOLVENTUM CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 1065 SOLVENTUM CORPORATION: DEALS
TABLE 1066 SOLVENTUM CORPORATION: OTHER DEVELOPMENTS
TABLE 1067 COGNIZANT: COMPANY OVERVIEW
TABLE 1068 COGNIZANT: PRODUCTS & SERVICES OFFERED
TABLE 1069 COGNIZANT: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1070 COGNIZANT: DEALS
TABLE 1071 VIZ.AI, INC.: COMPANY OVERVIEW
TABLE 1072 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED
TABLE 1073 VIZ.AI, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1074 VIZ.AI, INC.: DEALS
TABLE 1075 VIZ.AI, INC.: OTHER DEVELOPMENTS
TABLE 1076 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW
TABLE 1077 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
TABLE 1078 RIVERAIN TECHNOLOGIES: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS
TABLE 1079 RIVERAIN TECHNOLOGIES: DEALS
TABLE 1080 STUDY ASSUMPTIONS
TABLE 1081 AI IN HEALTHCARE MARKET: RISK ASSESSMENT

List of Figures

FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE
FIGURE 2 DURATION COVERED IN REPORT
FIGURE 3 MARKET SCENARIO
FIGURE 4 GLOBAL AI IN HEALTHCARE MARKET, 2024-2031
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023-2026
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF AI IN HEALTHCARE MARKET
FIGURE 7 HIGH-GROWTH SEGMENTS IN AI IN HEALTHCARE MARKET, 2026-2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN AI IN HEALTHCARE MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9 RAPID PROLIFERATION OF AI IN HOSPITALS TO DRIVE GROWTH OF AI IN HEALTHCARE MARKET
FIGURE 10 CLINICAL APPLICATIONS AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025
FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE IN GLOBAL AI IN HEALTHCARE MARKET DURING FORECAST PERIOD
FIGURE 12 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 AI IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 14 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 AI IN HEALTHCARE ECOSYSTEM ANALYSIS
FIGURE 16 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESSES
FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR AI IN HEALTHCARE MARKET
FIGURE 19 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN HEALTHCARE MARKET (JANUARY 2015 TO DECEMBER 2025)
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 21 KEY BUYING CRITERIA FOR TOP 3 END USERS
FIGURE 22 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT
FIGURE 23 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT
FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2021-2025
FIGURE 25 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2025
FIGURE 26 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 27 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT, 2025
FIGURE 28 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 29 EV/EBITDA OF KEY VENDORS, 2026
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026
FIGURE 31 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 33 MICROSOFT CORPORATION: COMPANY SNAPSHOT
FIGURE 34 NVIDIA CORPORATION: COMPANY SNAPSHOT
FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 37 ORACLE: COMPANY SNAPSHOT
FIGURE 38 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT
FIGURE 39 IBM: COMPANY SNAPSHOT
FIGURE 40 MEDTRONIC: COMPANY SNAPSHOT
FIGURE 41 GOOGLE: COMPANY SNAPSHOT
FIGURE 42 SOPHIA GENETICS: COMPANY SNAPSHOT
FIGURE 43 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
FIGURE 44 TEMPUS: COMPANY SNAPSHOT
FIGURE 45 SOLVENTUM CORPORATION: COMPANY SNAPSHOT
FIGURE 46 COGNIZANT: COMPANY SNAPSHOT
FIGURE 47 RESEARCH DESIGN
FIGURE 48 KEY DATA FROM SECONDARY SOURCES
FIGURE 49 PRIMARY SOURCES
FIGURE 50 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 52 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 53 BOTTOM-UP APPROACH: END USER SPENDING ON AI IN HEALTHCARE
FIGURE 54 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 55 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 56 TOP-DOWN APPROACH
FIGURE 57 DATA TRIANGULATION METHODOLOGY

Artificial Intelligence (AI) in Healthcare Market by Function (Imaging, Robotics, AI Scribe, Telehealth, CDS, Precision Medicine, Radiation, RCM, Cybersecurity), Tools (ML, NLP, Computer Vision), End User (Hospital, ASC, Payer) - Global Forecast to 2031

Description

Table of Contents

List of Tables

The breakdown of primary participants is as mentioned below:

This report provides insights on:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

7 REGULATORY LANDSCAPE

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

9 AI IN HEALTHCARE MARKET, BY FUNCTION

10 AI IN HEALTHCARE MARKET, BY OFFERING

11 AI IN HEALTHCARE MARKET, BY APPLICATION

12 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL

13 AI IN HEALTHCARE MARKET, BY TOOL

14 AI IN HEALTHCARE MARKET, BY END USER

15 AI IN HEALTHCARE MARKET, BY REGION

16 COMPETITIVE LANDSCAPE

17 COMPANY PROFILES

18 RESEARCH METHODOLOGY

19 APPENDIX

List of Tables

List of Figures